While chondroitin sulfate and glucosamine sulfate both have well-documented, beneficial effects in patients with osteoarthritis, the exact molecular actions of these drugs are also unknown.

U.S. consumers spent $753 million in 2012 on supplements of glucosamine and chondroitin in an attempt to relieve pain and stiffness from arthritis, according to the Nutrition Business Journal.